Bisphosphonates for the prevention and treatment of osteoporosis
about
Intravital imaging reveals new ancillary mechanisms co-opted by cancer cells to drive tumor progressionDistal humerus fractures: a review of current therapy conceptsSynthetic Procedures Leading towards AminobisphosphonatesUsing GWAS to identify novel therapeutic targets for osteoporosis.Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis.The Role of KV7.3 in Regulating Osteoblast Maturation and MineralizationThe impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison ServiceEffects of Chinese herbal formula Erxian decoction for treating osteoporosis: a systematic review.Postmenopausal Breast Cancer, Aromatase Inhibitors, and Bone Health: What the Surgeon Should Know.Persistence with denosumab and zoledronic acid among older women: a population-based cohort study.A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.Acceleration of osteoblast differentiation by a novel osteogenic compound, DMP-PYT, through activation of both the BMP and Wnt pathwaysThird-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up.Bisphosphonates prevent age-related weight loss in Japanese postmenopausal women.Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.Calcium Phosphates as Delivery Systems for Bisphosphonates.Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study.Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.Self-assembling bisphosphonates into nanofibers to enhance their inhibitory capacity on bone resorption.Melatonin reversed tumor necrosis factor-alpha-inhibited osteogenesis of human mesenchymal stem cells by stabilizing SMAD1 protein.Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.Five Decades of Hormone Therapy Research: The Long, the Short, and the Inconclusive
P2860
Q26745311-550661D6-1BDE-40F5-BE26-9759FE2F46CFQ26753074-3E00162D-7C49-4D99-80E6-BCB4352B5067Q28074725-6873107F-9B67-4813-8201-53CF06AF9B42Q30275429-89F0B79E-DF63-4A40-AB21-0F2ACC434D48Q36113758-73F357E2-A7FC-438D-9917-0F0D9EBC9F97Q36743799-B00021BA-C56E-42CD-A7D4-7BA9BE608C89Q37427443-1CEE1299-8C52-4A9D-8B75-5087661F022AQ37573172-8C15B02B-F543-44B6-81A8-54130B830E06Q38836713-5504AD97-2F07-49E6-BB3E-659218E5F226Q39344669-D38F6536-9400-48AA-8937-F0A21F3A3E0DQ39434182-46B798B5-5AB7-461B-B7F4-AA664D44BAECQ41436844-BC2882F7-71CA-464E-B307-F3C1012BF510Q46051482-955DB4DE-818E-400C-9894-73A103CB8E46Q47174018-B2EC22C9-EAC6-44D6-86AA-E85038A7E9B6Q47552430-1728EE45-B3AD-46DB-A8CB-49AA905BC951Q48225915-CE913867-10F3-47F7-B553-33AA831A7112Q49831235-2CADF509-EFBE-40A7-86F6-9B8137FB7D8CQ50040233-0B140289-AC02-4EE6-A9AF-7652186E136DQ51342272-9E1D7BA3-F623-4BB1-9851-CC5AAA1338E8Q51718842-D7DACE0A-F47D-4D7C-AC0D-6932736129CCQ52985345-24579E75-2C88-435F-9A37-47099DFF94B5Q54223105-3BA9E93C-888E-4994-A908-26AC6C0F44B6Q56673117-3D36D6B7-AF4F-4116-9105-291A4A03A381
P2860
Bisphosphonates for the prevention and treatment of osteoporosis
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Bisphosphonates for the prevention and treatment of osteoporosis
@ast
Bisphosphonates for the prevention and treatment of osteoporosis
@en
Bisphosphonates for the prevention and treatment of osteoporosis
@nl
type
label
Bisphosphonates for the prevention and treatment of osteoporosis
@ast
Bisphosphonates for the prevention and treatment of osteoporosis
@en
Bisphosphonates for the prevention and treatment of osteoporosis
@nl
prefLabel
Bisphosphonates for the prevention and treatment of osteoporosis
@ast
Bisphosphonates for the prevention and treatment of osteoporosis
@en
Bisphosphonates for the prevention and treatment of osteoporosis
@nl
P3181
P356
P1433
P1476
Bisphosphonates for the prevention and treatment of osteoporosis
@en
P2093
Kurt A Kennel
Spyridoula Maraka
P3181
P356
10.1136/BMJ.H3783
P407
P577
2015-01-01T00:00:00Z